Delivery Order SPE2DB22D3301-SPE2DB24FX7RK
Award Date 12/26/23
Potential Completion Date 12/27/23
Potential Value $24K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Deferasirox 500 mg tablets for suspension, with a total ceiling value of $2,169.38 and a period of performance through February 6, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,583.96, is a Delivery Order for the supply of 4,566,199 units of the drug Deferasirox 360 mg Tablet, packaged in 30s. The contract has an ultimate completion date of October 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The award is for the delivery of 4564001433 DEFERASIROX 500 MG TB FOR SUSP 30S, a pharmaceutical product, with a ceiling value of $2,483.12 and a period of performance through March 19, 2024. This is a firm fixed price delivery order contract that does not have a set-aside...
- This contract award is for the delivery of Deferasirox 500 mg tablets for suspension, a medication used to treat chronic iron overload, to the Defense Logistics Agency (DLA). The $2,414.80 firm-fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $58,786.52, is for the delivery of 4,567,105,531 units of the medication Deferasirox 500 mg tablets for suspension. This is a firm fixed-price delivery order contract, with a period of performance running through January 31, 2025. The contract does not have a set-aside designation, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $86,425.17 Firm Fixed Price Delivery Order contract is for the supply of 4567057652 - DEFERASIROX 360 MG TABLET 30S, with a performance period ending on January 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $39,804.59 firm-fixed-price delivery order is for the supply of 4,566,266,099 tablets of the drug deferasirox 360 mg. The contract has an ultimate completion date of October 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $13,953.48 fixed-price delivery order is for the supply of Deferasirox 360 mg tablets, with a completion date of June 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DEFERASIROX 360 MG TABLET 30S. The firm fixed price contract has a potential value of $13,105.98 and a performance completion date of December 29, 2023. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to supply pharmaceuticals, medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Deferasirox 360 mg tablets (30-count packages) under a firm fixed-price contract type. The award, valued at approximately $24.9K, was competitively awarded without set-aside designation and carries an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from...